Prof. Deepti Pandita, Delhi Pharmaceutical Sciences & Research University, New Delhi, India
Prof. Deepti Pandita is a distinguished academic and professional serving as a Professor at the Delhi Pharmaceutical Sciences & Research University (DPSRU), New Delhi, India, since May 2020. She holds key leadership roles as the PhD Coordinator and the Training & Placement Head at DPSRU, contributing significantly to academic administration and student career development.
Education
PhD in Pharmaceutics (2008)
Institution: Jamia Hamdard, Hamdard University, New Delhi
Thesis Topic: “Development and evaluation of submicron lipid nanoparticles for the oral delivery of paclitaxel”
Fellowship: ICMR – Senior Research Fellow (2005–2008)
Reference: SR/FT/LS145/2011
Master of Pharmacy in Pharmaceutics (2002)
Institution: Manipal College of Pharmaceutical Sciences, MAHE, Karnataka
Aggregate: 78.86%
Bachelor of Pharmacy (1997)
Institution: Mysore University, Karnataka
Aggregate: 74.59%
MBA in Marketing (2013)
Institution: M. D. University, Rohtak (Distance Mode)
Aggregate: 66.11%
Higher Secondary Education (XII Class) (1995)
Board: CBSE, Delhi
Aggregate: 63%
Secondary Education (X Class) (1993)
Board: CBSE, Delhi
Aggregate: 78%
Registered Pharmacist
Registration Number: 14991
Date: 11.10.2002
Issuing Authority: Delhi Pharmacy Council
Professional Profiles
Google Scholar
ORCID Profile
Professional Experience
Professor
Delhi Pharmaceutical Sciences & Research University (DPSRU), Govt. of NCT of Delhi, New Delhi, India
May 27, 2020 – Present
Associate Professor
Amity University Uttar Pradesh, Noida
June 4, 2018 – April 4, 2020
Professor & Head
JCDM College of Pharmacy, Sirsa
October 12, 2012 – June 1, 2018
Associate Professor & Head
JCDM College of Pharmacy, Sirsa
August 18, 2010 – October 11, 2012
Postdoctoral Fellow
CQM, University of Madeira, Portugal
June 1, 2008 – July 31, 2010
Assistant Professor
SBMN Institute of Pharmaceutical Sciences & Research, M.D. University, Rohtak
September 24, 2002 – July 31, 2003
Research Interests
Nanomedicine & Nanotheranostics
Bioconjugates
Stem Cell Research for Tissue Engineering
Drug Discovery & Repurposing
3D Printing for Personalized & Precision Medicine
Targeted Phytochemical Delivery
Top Notable Publications
Therapeutic Potential of Isoliquiritigenin in Breast Cancer
Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology (2024)
DOI: 10.1007/s00210-024-03282-6
Contributors: Divya Sharma, Mahaveer Dhobi, Viney Lather, Deepti Pandita
This research explores the therapeutic effects of isoliquiritigenin on breast cancer treatment.
CDC20 Inhibitors in Breast Cancer
Journal: 3 Biotech (2023)
DOI: 10.1007/s13205-023-03554-7
Contributors: Amiya Das, Hitesh Kumar Sharma, Viney Lather, Deepti Pandita, Pallavi Agarwal
Focuses on the identification and evaluation of CDC20 inhibitors as potential therapeutic agents for breast cancer.
Drug Repurposing for Triple-Negative Breast Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry (2022)
DOI: 10.2174/1871520621666211021143255
Contributors: Amiya Das, Pallavi Agarwal, Gaurav Kumar Jain, Geeta Aggarwal, Viney Lather, Deepti Pandita
Examines novel therapeutic options through drug repurposing for aggressive breast cancer types.
Protective Effects of Dalbergia sissoo
Journal: Turkish Journal of Pharmaceutical Sciences (2021)
DOI: 10.4274/tjps.galenos.2020.04379
Contributors: Raheja S., Girdhar A., Kamboj A., Lather V., Pandita D.
Studies the neuroprotective effects of Dalbergia sissoo against oxidative stress and memory impairment.
Phytoconstituents in COVID-19 Management
Journal: Chemico-Biological Interactions (2021)
DOI: 10.1016/j.cbi.2021.109449
Contributors: Das A., Pandita D., Jain G.K., Agarwal P., Grewal A.S., Khar R.K., Lather V.
Explores the potential of phytoconstituents in combating COVID-19.
Biomedical Applications of Extracellular Matrix Extraction Techniques
Journal: Regenerative Medicine (2021)
DOI: 10.2217/rme-2021-0021
Contributors: Kirthanashri S. Vasanthan, Varadharajan Srinivasan, Deepti Pandita
Discusses innovative extracellular matrix techniques for biomedical engineering.
Paclitaxel Hybrid Nanoparticles for Cancer Therapy
Journal: Materials Science and Engineering C (2020)
DOI: 10.1016/j.msec.2019.110576
Contributors: Godara S., Lather V., Kirthanashri S.V., Awasthi R., Pandita D.
Details advancements in lipid-PLGA nanoparticles for enhanced cancer treatment.
Cinnamic Acid Derivatives for Metabolic Syndrome
Journal: Current Drug Discovery Technologies (2020)
DOI: 10.2174/1570163816666190314124543
Contributors: Chauhan A., Grewal A.S., Pandita D., Lather V.
Investigates novel cinnamic acid derivatives as PPARδ agonists.
Methotrexate and Resveratrol Nanoemulsions
Journal: Assay and Drug Development Technologies (2020)
DOI: 10.1089/adt.2020.989
Contributors: Poonia N., Lather V., Kaur B., Kirthanashri S.V., Pandita D.
Optimizes nanoemulsions for rheumatoid arthritis treatment.
Resveratrol-Loaded Nanoparticles
Journal: Materials Science and Engineering C (2020)
DOI: 10.1016/j.msec.2020.111016
Contributors: Poonia N., Lather V., Narang J.K., Beg S., Pandita D.
Develops lipoprotein-mimetic nanoparticles for improved drug delivery systems.
Conclusion
Prof. Deepti Pandita is a highly deserving candidate for the “Research for Best Researcher Award,” with her strong foundation in impactful research, innovative methodologies, and multidisciplinary expertise. Her contributions to oncology, neuropharmacology, and drug delivery systems stand out as significant advancements in the field of pharmacology.